Cardiac Rhythms and Shock (Ventricular Rhythms, Arrhythmias, and Types of Shock)

# Lecture Summary

Subject: Cardiac Rhythms and Shock (Ventricular Rhythms, Arrhythmias, and Types of Shock)

## Key Learning Points

- Distinction between ventricular rhythms (ventricular tachycardia, ventricular fibrillation, asystole, PVCs/PACs) and atrial rhythms; emphasis on life-threatening nature of some ventricular rhythms and the need to check perfusion (pulse) immediately.

- Ventricular tachycardia (V-tach): wide, regular QRS complexes, heart rate > 100 bpm; patient may be perfusing or pulseless — always check pulse; can rapidly decompensate.

- Ventricular fibrillation (V-fib): chaotic, uncoordinated electrical activity, no cardiac output, no pulse — immediate CPR and defibrillation required.

- Asystole: flatline, no electrical activity, no cardiac output.

- Premature ventricular contractions (PVCs) and premature atrial contractions (PACs): extra beats from ectopic foci; often benign but can indicate instability when occurring in long runs.

- Immediate actions and medications for arrhythmias (vagal maneuvers, adenosine, amiodarone, vasopressors, defibrillation, CPR) and the rationale behind stopping/restarting the heart in controlled settings.

- Shock: pathophysiology (loss of forward flow/cardiac output → cellular hypoxia → compensatory vasoconstriction → inflammatory mediator release → anaerobic metabolism → lactic acidosis → progressive organ dysfunction).

- Types of shock: hypovolemic, cardiogenic, distributive (septic, anaphylactic, neurogenic) — causes, clinical signs, diagnostics, and first-line treatments differ by type.

- Sepsis and septic shock: SIRS criteria and screening, common pathogens, high morbidity/mortality, complications (ARDS, acute kidney injury, DIC, MODS), and treatment priorities (cultures, broad-spectrum antibiotics, fluids, vasopressors, glucose control).

- In-class active learning: small-group activity on heart failure and arrhythmia cases (groups of 4–5, bring a device for reference).

## Definitions

- Ventricular tachycardia (V-tach): A ventricular-origin tachyarrhythmia with wide, bizarre QRS complexes, regular rhythm, heart rate > 100 beats per minute; may be pulseless or have pulse.

- Ventricular fibrillation (V-fib): Disorganized, chaotic ventricular electrical activity with no effective ventricular contraction and no cardiac output (pulseless).

- Asystole: Absence of electrical activity on ECG; “flatline”; no cardiac output.

- Premature ventricular contraction (PVC): An early ventricular beat originating from an ectopic ventricular focus.

- Premature atrial contraction (PAC): An early atrial beat originating from an ectopic atrial focus.

- Automaticity: The heart muscle cells’ intrinsic ability to generate electrical impulses without external stimuli.

- Perfusion: Forward blood flow sufficient to maintain tissue oxygenation and organ function.

- Circulatory shock: A state of inadequate tissue perfusion and oxygen delivery due to failure of the circulatory system; includes multiple etiologies.

- Hypovolemic shock: Shock caused by inadequate intravascular volume (e.g., hemorrhage, dehydration, burns).

- Cardiogenic shock: Shock caused by failure of the heart as a pump (e.g., large MI, severe arrhythmia, tamponade).

- Distributive shock: Shock caused by abnormal distribution of blood flow (vasodilation); major types include septic, anaphylactic, and neurogenic.

- Sepsis: Life-threatening organ dysfunction caused by a dysregulated host response to infection.

- SIRS (Systemic Inflammatory Response Syndrome): Clinical criteria used to detect systemic inflammation and possible sepsis (fever, WBC abnormalities including bands, tachycardia, tachypnea).

- MODS (Multiple Organ Dysfunction Syndrome): Progressive organ dysfunction in an acutely ill patient, often following shock or severe sepsis.

- DIC (Disseminated Intravascular Coagulation): Pathologic activation of coagulation leading to microthrombi and subsequent depletion of clotting factors → bleeding.

- ARDS (Acute Respiratory Distress Syndrome): Severe inflammatory lung injury causing hypoxemic respiratory failure.

- AKI (Acute Kidney Injury): Sudden reduction in kidney function, commonly seen early in shock.

- Vagal maneuvers: Techniques (bearing down, Valsalva, blowing through a straw) used to increase vagal tone and potentially terminate certain tachyarrhythmias.

- Adenosine: A rapid-acting antiarrhythmic used in controlled settings to transiently block AV nodal conduction and potentially terminate re-entrant supraventricular tachycardias (note: instructor described its effect as "stopping the heart briefly to restart into a normal rhythm").

- Amiodarone: An antiarrhythmic used for ventricular and supraventricular arrhythmias and for rate control in certain contexts.

- Vasopressors: Medications (e.g., epinephrine, vasopressin) used to raise systemic vascular resistance and support blood pressure during shock.

- Inotropic agents: Medications that increase the force of cardiac contraction (improve "squeeze").

## Detailed Topic Notes

[Topics follow the sequence presented during the lecture and capture instructor explanations, examples, pathophysiology, and management recommendations.]

### Ventricular rhythms and related arrhythmias

The instructor transitioned from atrial rhythms to ventricular rhythms and emphasized that many ventricular rhythms can be life-threatening.

- Ventricular tachycardia (V-tach)

- Appearance and rhythm: V-tach presents as wide, bizarre QRS complexes and is a regular rhythm. Heart rate is typically over 100 bpm.

- Perfusion status: Patients may or may not be perfusing (may have a pulse or be pulseless). Because of this variability, always check a pulse immediately when V-tach is observed on a monitor.

- Clinical presentation: Patients can be symptomatic (dizziness, shortness of breath, loss of consciousness) or asymptomatic (appearing alert and acting normally), but even those who appear well will often decompensate if rhythm persists.

- Immediate management: First step is to assess pulse/perfusion. If patient is pulseless, treat as cardiac arrest (CPR and defibrillation as indicated). If the patient has a pulse but is unstable, synchronized cardioversion and urgent rhythm management are needed.

- Treatments discussed:

- Vagal maneuvers (bearing down, blowing through a straw) may be attempted in a controlled setting with a team present because maneuvers can provoke deterioration requiring immediate resuscitation.

- Medications mentioned: adenosine (used in controlled settings; instructor emphasized it can transiently stop the heart to re-establish a normal rhythm), amiodarone (for rate/rhythm control).

- Cardiologist involvement, potential cardioversion.

- Causes: Coronary artery disease, myocardial infarction, heart failure, long QT syndromes, and electrolyte/drug effects. Runs of ventricular ectopy can progress to sustained V-tach.

- Ventricular fibrillation (V-fib)

- Pathophysiology: Chaotic, uncoordinated ventricular electrical activity leading to no effective ventricular contraction and no cardiac output.

- Clinical status: Immediately pulseless with no forward flow.

- Immediate management: Start CPR immediately; prepare for prompt defibrillation (unsynchronized shock). Instructor stressed that CPR should not be delayed while preparing pads/defibrillator; CPR is the immediate action.

- Goal: Electrical defibrillation is intended to depolarize myocardial cells briefly so that normal pacemaker activity (SA/AV node) can resume and re-establish coordinated rhythm.

- Asystole

- Description: Flatline; absence of electrical activity; no cardiac output.

- Management: CPR and resuscitative measures (instructor did not detail specific medications here beyond general resuscitation measures).

- Premature ventricular contractions (PVCs) and premature atrial contractions (PACs)

- Description: Extra early beats originating from ectopic foci in the ventricle (PVC) or atrium (PAC). Reflect automaticity in ectopic sites.

- Clinical relevance: Many patients experience isolated PVCs/PACs (may feel like "extra heartbeats"). They are common after myocardial infarction, procedures, and in patients with heart disease; they may also occur with alcohol, smoking, stimulant drug use (e.g., cocaine), stress, or anxiety.

- Concern: Frequent PVCs or long runs (multiple in a row) can be concerning and may require cardiology notification/management.

In-class Exercise/Activity:

- None identified within this Topic.

### Immediate treatments and medications for arrhythmias (intermingled with rhythm descriptions)

- Check perfusion (pulse) for any ventricular rhythm detected.

- If pulseless (V-tach pulseless or V-fib): Start CPR immediately and prepare for defibrillation.

- If patient has pulse but unstable: team-based interventions—cardioversion, antiarrhythmic drugs, possible sedation prior to adenosine or cardioversion if planned.

- Specific medications referenced:

- Adenosine: used in controlled settings to interrupt re-entrant tachycardias; transiently stops conduction (and may be perceived as "stopping the heart") so rhythm can restart normally. Requires monitoring and team availability because of risk of deterioration.

- Amiodarone: used for rate/rhythm control for ventricular arrhythmias.

- Vasopressors (epinephrine, vasopressin) and other agents can be used during resuscitation attempts to support circulation and help the heart restart.

- Mechanical therapy:

- Defibrillation for pulseless V-tach and V-fib; synchronized cardioversion for unstable tachycardia with pulse.

### Shock: pathophysiology, stages, and general manifestations

- Definition and significance: Shock is a life-threatening systemic state where forward flow and tissue oxygen delivery are inadequate; untreated shock is fatal. Different etiologies lead to the same final common pathway — inadequate perfusion and cellular hypoxia.

- Cellular/physiologic cascade:

- Initial compensation includes intense vasoconstriction to preserve central perfusion (brain, heart, lungs) at the expense of peripheral organs.

- Inflammatory mediators and histamine release accompany shock physiology, contributing to metabolic impairment.

- As perfusion fails at the cellular level, cells shift from aerobic to anaerobic metabolism, generating limited ATP and producing lactic acid and other toxic byproducts (lactic acidosis), which worsen cellular dysfunction.

- Progressive cellular swelling and membrane failure lead to organ injury and then organ failure.

- Over time compensation fails; vasoconstriction cannot be maintained indefinitely → vasodilation and worsening hypotension. This leads to hypotension, rising lactic acid, oliguria (low urine output), tachycardia, increased respiratory rate (to blow off acid and attempt pH regulation), altered level of consciousness, and cold/clammy skin (as skin perfusion is sacrificed).

- Common vulnerable organs: Kidneys (often first to show failure), liver, lungs, brain, heart. Multiple organ dysfunction syndrome (MODS) occurs as more organ systems fail — mortality increases significantly with two or more failing organ systems.

- General signs across shock types: tachycardia, hypotension, decreased urine output, increased respiratory rate, altered mental status, cold/clammy skin (early vasoconstriction then eventual vasodilation and cool extremities).

### Types of shock and management

- Hypovolemic shock

- Cause: Low intravascular volume from hemorrhage, burns (fluid loss), severe dehydration, vomiting/diarrhea, diabetes insipidus (translational note: lecture referenced diabetes insipidus), post-surgical bleeding, trauma.

- Diagnostics/labs to assess volume loss: electrolytes (lytes), CBC with hemoglobin and hematocrit (H&H) to assess for blood loss, lactate as a marker of perfusion.

- Management: Restore volume — isotonic crystalloids (normal saline, lactated Ringer's), blood products for hemorrhage, colloids/plasma as indicated. Identify and control the source of volume loss (stop bleeding, treat burns/dehydration).

- Cardiogenic shock

- Cause: Pump failure (e.g., large myocardial infarction, severe arrhythmia, tamponade).

- Management: Improve cardiac function — inotropic agents, medications to optimize cardiac output, mechanical support if needed (pacemakers, implantable cardioverter-defibrillators, other advanced cardiac support), treat underlying cause (revascularization post-MI).

- Distributive shock (includes septic, anaphylactic, neurogenic)

- Septic shock (distributive)

- Cause: Infection leading to systemic inflammatory response and inappropriate vasodilation and capillary leak; can be bacterial (common: gram-negative organisms such as E. coli, Klebsiella, Pseudomonas; gram-positive such as Staph and Strep), viral, or fungal.

- Risk groups: elderly, very young, immunocompromised, hospitalized patients, patients with comorbidities (e.g., cancer). Sepsis is a major cause of mortality; instructor cited sepsis mortality broadly 20–40% and that septic shock mortality remains high (about one-third die in some contexts); comorbidities can raise mortality (in lecture, up to 70% with underlying comorbidities — instructor context: dependent on severity and comorbid conditions).

- Screening: SIRS criteria and sepsis screening checks in hospitals (fever, abnormal WBC or bandemia indicating increased immature neutrophils, tachycardia, tachypnea). A met threshold (e.g., two or more criteria) triggers sepsis flags and warrants further workup and escalation.

- Diagnostics: Blood cultures (obtain before antibiotics if possible), lactic acid, CBC, electrolytes, organ-specific labs.

- Management priorities: Early broad-spectrum IV antibiotics (do not wait for culture results — start empiric therapy), aggressive fluids to restore intravascular volume, vasopressors if hypotension persists after fluids, source control, and later tailoring antibiotics based on cultures. Glucose control is important because hyperglycemia promotes bacterial growth.

- Complications: ARDS (lung failure), acute kidney injury, DIC (consumptive coagulopathy — lecture emphasized strong association between sepsis and DIC), MODS.

- Anaphylactic shock (distributive)

- Cause: Type I hypersensitivity reaction; massive histamine-mediated vasodilation and increased capillary permeability.

- Immediate treatment: Epinephrine is first-line therapy (instructor referenced epinephrine).

- Neurogenic shock (distributive)

- Cause: Loss of sympathetic tone typically from spinal cord injury; leads to hypotension and bradycardia sometimes with warm, flushed skin (loss of vasoconstrictive tone).

- Management focus: Maintain blood pressure and perfusion, support spinal cord injury protocols; more neuro content to be covered later in course.

### Sepsis in greater detail (screening, lab clues, complications)

- SIRS and screening: In-hospital sepsis screens are used commonly; if patient meets two SIRS criteria (e.g., fever, tachycardia, tachypnea, leukocytosis or leukopenia with bandemia), an alert is triggered and further sepsis workup is initiated.

- Lab clues: Elevated lactic acid as marker of tissue hypoperfusion; white blood cell counts and band counts (bandemia indicates immature neutrophils being produced in response to infection); electrolytes and H&H to assess volume status and bleeding.

- Treatment sequence: Obtain cultures first (blood, other sources), begin broad-spectrum antibiotics immediately, give IV fluids, consider vasopressors if hypotensive after fluid resuscitation, control blood glucose, provide ICU-level care for severe cases.

- Complications and prognostic indicators: Development of ARDS, acute kidney injury, DIC, and progression to MODS significantly worsens prognosis. Instructor emphasized the high mortality and variability depending on timeliness of recognition, comorbidities, and source of infection.

### Summary and transition to active learning activity

- Instructor reiterated key differences in arrhythmia recognition and immediate actions (pulse check, CPR, defibrillation) and the need to recognize shock early and identify its type to guide treatment (volume replacement for hypovolemia, cardiac support for cardiogenic shock, antibiotics/fluids for sepsis).

- Instructor announced an in-class group activity on heart failure and arrhythmias to be done outside in small groups (details below).

In-class Exercise/Activity:

- Activity: Heart failure and arrhythmia cases (hands-on, small-group).

- Groups: Approximately 4–5 students per group.

- Logistics: Instructor indicated groups should bring a laptop or phone if possible for reference; activity to be completed outside (location to be determined by instructor).

- Instructor planned to provide materials and follow-up; students to work collaboratively on the cases.

## Questions and Answers Highlights

- No dedicated, standalone Q&A session was identified; multiple student questions and brief interactions occurred during lecture and were incorporated into the relevant topic sections (examples: students asked about causes of hypovolemia such as severe anemia and were told that severe anemia could cause similar manifestations; students shared experiences feeling extra heartbeats; band count/bandemia explained as “baby neutrophils”).

## Exam Callouts

- Instructor explicitly emphasized the close relationship between sepsis and DIC and stated that this association is likely testable: "DIC and sepsis are best friends" — remember the association (sepsis can precipitate DIC; consume clotting factors → bleeding).

- Instructor noted monitoring SIRS/sepsis screening and early recognition as clinically and exam-relevant.